A detailed history of Plancorp, LLC transactions in Amgen Inc stock. As of the latest transaction made, Plancorp, LLC holds 2,805 shares of AMGN stock, worth $779,453. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,805
Previous 2,764 1.48%
Holding current value
$779,453
Previous $863,000 4.63%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $12,684 - $13,832
41 Added 1.48%
2,805 $903,000
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $1,576 - $1,915
6 Added 0.22%
2,764 $863,000
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $40,330 - $48,684
150 Added 5.75%
2,758 $784,000
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $32,985 - $37,211
129 Added 5.2%
2,608 $751,000
Q3 2023

Nov 08, 2023

BUY
$218.65 - $271.46 $3,498 - $4,343
16 Added 0.65%
2,479 $666,000
Q2 2023

Jul 26, 2023

SELL
$214.27 - $253.37 $6,642 - $7,854
-31 Reduced 1.24%
2,463 $546,000
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $23,707 - $28,896
-105 Reduced 4.04%
2,494 $602,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $6,870 - $8,730
30 Added 1.17%
2,599 $682,000
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $5,387 - $6,075
-24 Reduced 0.93%
2,569 $579,000
Q2 2022

Aug 04, 2022

SELL
$230.71 - $256.74 $7,844 - $8,729
-34 Reduced 1.29%
2,593 $631,000
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $19,515 - $21,588
89 Added 3.51%
2,627 $635,000
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $13,324 - $15,249
-67 Reduced 2.57%
2,538 $571,000
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $37,571 - $44,019
177 Added 7.29%
2,605 $554,000
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $11,679 - $12,957
-50 Reduced 2.02%
2,428 $592,000
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $8,654 - $10,085
39 Added 1.6%
2,478 $617,000
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $54,744 - $65,190
253 Added 11.57%
2,439 $561,000
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $85,647 - $95,246
-365 Reduced 14.31%
2,186 $556,000
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $13,253 - $16,263
67 Added 2.7%
2,551 $602,000
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $54,489 - $72,268
299 Added 13.68%
2,484 $503,000
Q4 2019

Feb 03, 2020

BUY
$189.21 - $243.2 $34,814 - $44,748
184 Added 9.2%
2,185 $527,000
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $4,004 - $4,798
23 Added 1.16%
2,001 $387,000
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $1.25 Million - $1.47 Million
-7,512 Reduced 79.16%
1,978 $364,000
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $72,709 - $81,959
402 Added 4.42%
9,490 $1.8 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $41,924 - $48,938
-235 Reduced 2.52%
9,088 $1.77 Million
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $5,929 - $6,684
32 Added 0.34%
9,323 $1.93 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $21,088 - $23,686
-127 Reduced 1.35%
9,291 $1.72 Million
Q1 2018

Apr 16, 2018

BUY
$169.43 - $198.0 $40,154 - $46,926
237 Added 2.58%
9,418 $1.61 Million
Q4 2017

Jan 19, 2018

SELL
$168.79 - $188.59 $58,232 - $65,063
-345 Reduced 3.62%
9,181 $1.6 Million
Q3 2017

Oct 11, 2017

BUY
$167.29 - $191.0 $1.59 Million - $1.82 Million
9,526
9,526 $1.78 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Plancorp, LLC Portfolio

Follow Plancorp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.